Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003Astri Fjelde Maaland, Jostein Dahle, Véronique Pascal et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019Cited by 16
Abstract 848: In vitro and in vivo evaluation of the beta-emitting lutetium-177 labeled anti-CD37 antibody radionuclide conjugate 177Lu-NNV003 in DLBCL, CLL and MCL modelsAstri Fjelde Maaland, Jostein Dahle, Helèn Heyerdahl et al.|Cancer Research|2018Cited by 0